Search

everythinglearnresearchcommunity

for

Search:↓

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Policemen have more hair loss due to obesity, sunlight exposure, and stress.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Babies who gain weight quickly, especially in the first 3 months, may start puberty earlier.

Bald men may have a lower risk of testicular cancer.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

MendelVar is a tool that helps identify important genes by combining GWAS data with Mendelian disease information.

Older age, family history, and low iron levels increase the risk of female hair loss.

Vitamin E helps reduce PCOS symptoms and improves hormonal balance.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

People who are more materialistic often expect life changes from buying things, leading to more debt and credit misuse.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Alopecia in captive rhesus macaques is affected by season, sex, age, housing, and stress, with complex links between stress hormones and hair loss.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Hormonal therapies are safe and effective for treating adult women's acne.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Men with testicular cancer were less likely to experience baldness and severe acne.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.